Security key
04280A100
ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR)
CUSIP: 04280A100
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 72,976,301
- Total 13F value
- $1,851,849,623
- Share change
- -194,630
- Put/Call ratio
- 89%
- SEC-reported price per share
- $25.40
- Number of holders
- 250
- Value change
- -$23,671,296
- Number of buys
- 113
- Number of sells
- 140
- Shares outstanding
- 141,328,976
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2023
Institutions
250
Top holders
10
ARWR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Previous quarter: Q4 2022
ARROWHEAD PHARMACEUTICALS, INC. SEC filings
ARROWHEAD PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04280A100
Recent filing periods:
Ownership snapshot
Top reported holders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 9%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BlackRock Finance, Inc.
9%
VANGUARD GROUP INC
7.3%
STATE STREET CORP
4.2%
JPMORGAN CHASE & CO
2%
ALLIANCEBERNSTEIN L.P.
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
9%
|
$515,563,757
12,711,138 shares
|
— | 31 Dec 2022 |
| VANGUARD GROUP INC |
13F
Company
|
7.3%
|
$417,207,136
10,286,172 shares
|
— | 31 Dec 2022 |
| STATE STREET CORP |
13F
Company
|
4.2%
|
$242,157,153
5,970,344 shares
|
— | 31 Dec 2022 |
| JPMORGAN CHASE & CO |
13F
Company
|
2%
|
$114,413,000
2,820,822 shares
|
— | 31 Dec 2022 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
1.8%
|
$104,835,148
2,584,693 shares
|
— | 31 Dec 2022 |
| Invesco Ltd. |
13F
Company
|
1.5%
|
$88,599,345
2,184,402 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
250
Shares
72,976,301
Rows available
250
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
276
Q1 2023 holders
250
Holder diff
-26
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend